Analgesic effect of acupuncture compared with sham acupuncture in primary dysmenorrhoea: AAEPD-II

ISRCTN ISRCTN24863192
DOI https://doi.org/10.1186/ISRCTN24863192
Secondary identifying numbers 2006CB504503
Submission date
15/11/2008
Registration date
11/12/2008
Last edited
20/02/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Jiang Zhu
Scientific

Beijing University of Chinese Medicine
11 Bei San Huan Dong Lu
Chao Yang District
Beijing
100029
China

Phone +86 (0)10 8456 0099
Email 603005@bucm.edu.cn

Study information

Study designMulti-centre randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleAnalgesic effect of acupuncture compared with sham acupuncture in primary dysmenorrhoea: a multi-centre randomised controlled clinical trial-II
Study acronymAAEPD-II (Acupuncture Analgesia Effect in Primary Dysmenorrhoea-II)
Study objectivesSome recent randomised controlled trials (RCTs) suggested that acupuncture was no more effective than sham acupuncture. Because of small sample size in the previous study (50 patients in each arm) (ISRCTN84496835), we have a design for a larger sample of trial to evaluate the point specificity of analgesic effect of acupuncture at SP6 in primary dysmenorrhoea. For the primary outcome measure the Visual Analogue Scale (VAS) score for pain at baseline and 30 minutes after the first intervention, the previous study (ISRCTN84496835) suggested a 47.58% improvement for acupoint group, compared with 40.71% for non-acupoint group. We used these findings as the basis for our power calculation. At 5% significance and 80% power, 145 patients are required in each arm. Taking into consideration a 15% dropout rate, at least 167 patients in each arm are needed.
Ethics approval(s)Medical Ethics Committee of the Beijing University of Chinese Medicine, approved on 10/11/2008
Health condition(s) or problem(s) studiedPrimary dysmenorrhoea
Intervention1. Acupuncture
2. Sham acupuncture

Acupuncture and sham acupuncture were administered once-daily for 3 days with acupuncture at Sanyinjiao (SP6) that was specifically designed to treat primary dysmenorrhoea, or 1 of 2 sham acupuncture treatments: acupuncture for an unrelated acupoint (Xuanzhong, GB39), or needle insertion at non-acupoint locations (lateral side of lower leg, 3 inches above the tip of external malleolus, 1.5 inches behind anterior crest of the bibia).
Intervention typeOther
Primary outcome measure1. VAS score for pain at baseline, 5, 10, 30, and 60 minutes after the first intervention
2. Cox Retrospective Symptom Scale (RSS) during 3 menstrual cycles (before the treatment, during the treatment, and in 1 subsequent cycle after intervention)
3. Verbal Rating Scale (VRS) during 3 menstrual cycles (before the treatment, during the treatment, and in 1 subsequent cycle after intervention)
Secondary outcome measures1. Pain, as measured by VAS, before the second intervention, before the third intervention, and during 3 menstrual cycles
2. The changes in assigned analgesic medication usage that each participant reported using during 2 menstrual cycles (during the treatment and in 1 subsequent cycle after intervention), and proportion of participants in each group who were using analgesics in addition to their assigned treatment during 2 menstrual cycles (during the treatment and in 1 subsequent cycle after intervention)
Overall study start date01/12/2008
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants501
Key inclusion criteria1. Women aged 18 to 30 years
2. A history of regular menstruation (28-day cycle +/- 7 days)
3. Primary dysmenorrhoea (onset greater than or equal to 3 years after menarche)
4. Menstrual cramping pain of moderate or severe intensity, varying from 4.0 to 10.0 on VAS, and for at least 6 months before study entry
5. Not pregnant
6. Good general health
7. Agree to refrain from the use of any analgesics 24 hours before the first intervention
8. Provide written informed consent prior to enrolment
Key exclusion criteria1. Dysmenorrhoea secondary to organic pathology
2. A history of term pregnancy or possible current pregnancy
3. Severe gastrointestinal, gynaecological or autoimmune diseases, or gynaecological surgery
4. They have previously received acupuncture (to maximize blinding)
Date of first enrolment01/12/2008
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • China

Study participating centre

Beijing University of Chinese Medicine
Beijing
100029
China

Sponsor information

Ministry of Science and Technology (China)
Government

15B
Fuxing Road
Beijing
100862
China

Phone +86 (0)10 5888 1072
Email jcc973@vip.sina.com
Website http://www.most.gov.cn/eng/index.htm
ROR logo "ROR" https://ror.org/027s68j25

Funders

Funder type

Government

Ministry of Science and Technology (China) - National Basic Research Programme (ref: 2006CB504503)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2011 Yes No
Results article results 21/02/2014 Yes No
Results article results 01/06/2014 Yes No